IL13 and COVID-19: IL-6 and TNFα are central to the inflammatory response in COVID-19, and IL-13 has also been linked to disease severity, driving increased levels of eosinophils and macrophages in the lungs and stimulating smooth muscle hypertrophy and fibrosis [1,25,26,27].